Velius

Velius is a private U.S. biopharmaceutical company focused on prescription and over-the-counter products delivered through or targeting the skin. The company markets scar-care consumer products and is developing topical prescription programs in dermatology and related areas, with stated interests spanning scar treatment, psoriasis, eczema, pain, oncology, and animal health. Its core technology appears to be a patented Nanopatch nanotechnology film platform intended to enhance topical and transdermal delivery. Publicly available information suggests Velius is commercial in OTC scar care but remains early stage on its prescription pipeline, with no clearly disclosed human clinical-stage assets. The business is based in Great Neck, New York and is led by founder and CEO Joel R. Studin.